BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $11.42 million. The enterprise value is -$3.17 million.

Market Cap	11.42M
Enterprise Value	-3.17M

Important Dates

The next estimated earnings date is Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

BRTX has 6.92 million shares outstanding. The number of shares has increased by 61.36% in one year.

Shares Outstanding	6.92M
Shares Change (YoY)	+61.36%
Shares Change (QoQ)	+21.74%
Owned by Insiders (%)	19.43%
Owned by Institutions (%)	3.63%
Float	5.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.02
Forward PS	29.46
PB Ratio	1.06
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.01.

Current Ratio	2.82
Quick Ratio	2.76
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.65% and return on invested capital (ROIC) is -68.57%.

Return on Equity (ROE)	-32.65%
Return on Assets (ROA)	-54.82%
Return on Capital (ROIC)	-68.57%
Revenue Per Employee	$15,827
Profits Per Employee	-$344,323
Employee Count	11
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.63% in the last 52 weeks. The beta is 62.40, so BRTX's price volatility has been higher than the market average.

Beta (5Y)	62.40
52-Week Price Change	-27.63%
50-Day Moving Average	1.61
200-Day Moving Average	1.55
Relative Strength Index (RSI)	49.49
Average Volume (20 Days)	26,493

Short Selling Information

The latest short interest is 50,311, so 0.73% of the outstanding shares have been sold short.

Short Interest	50,311
Short Previous Month	58,394
Short % of Shares Out	0.73%
Short % of Float	0.99%
Short Ratio (days to cover)	1.72

Income Statement

In the last 12 months, BRTX had revenue of $174,100 and -$3.79 million in losses. Loss per share was -$0.63.

Revenue	174,100
Gross Profit	167,610
Operating Income	-12.90M
Pretax Income	-6.96M
Net Income	-3.79M
EBITDA	-12.73M
EBIT	-12.90M
Loss Per Share	-$0.63

Full Income Statement

Balance Sheet

The company has $14.68 million in cash and $83,580 in debt, giving a net cash position of $14.60 million or $2.11 per share.

Cash & Cash Equivalents	14.68M
Total Debt	83,580
Net Cash	14.60M
Net Cash Per Share	$2.11
Equity (Book Value)	10.80M
Book Value Per Share	1.56
Working Capital	9.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.95 million and capital expenditures -$117,268, giving a free cash flow of -$7.07 million.

Operating Cash Flow	-6.95M
Capital Expenditures	-117,268
Free Cash Flow	-7.07M
FCF Per Share	-$1.02

Full Cash Flow Statement

Margins

Gross Margin	96.27%
Operating Margin	-7,411.36%
Pretax Margin	-2,175.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,354.70%

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.36%
Shareholder Yield	-61.36%
Earnings Yield	-33.17%
FCF Yield	-61.90%

Analyst Forecast

The average price target for BRTX is $18.00, which is 990.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	990.91%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	266.76%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	0.00025:1

Scores

BRTX has an Altman Z-Score of -14.1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.1
Piotroski F-Score	1